For example, KLF5 has been identified as a therapeutic target in colorectal cancer, and a small molecule, compound CID 5951923, which specifically inhibits KLF5 expression, has been developed through high throughput screening [20]. The gene discussed is KLF5; the disease is colorectal cancer.